Skip to content
Screener
Zimmer Biomet Holdings logo

Zimmer Biomet Holdings

ZBH

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare.

Market cap
$19.34B-8.6%
Revenue$8.5B+8.6%
Net income$806.6M-2.0%
Free cash flow$1.5B+3.4%
EPS (diluted)$4.12+0.5%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$2.0B
EPS estimate$1.89

Financials

Q2 2026

Income statement

See full
Revenue$2.2B+4.8%
Gross profit$1.5B+3.8%
Operating income$326.1M+8.7%
Net income$198.3M+29.8%
EPS (diluted)$1.03+33.8%

Balance sheet

See full
Cash & equivalents$410.0M-26.4%
Total debt$7.5B-1.2%
Total equity$12.6B+0.8%
Total assets$22.8B-0.3%

Cash flow

See full
Operating cash flow$447.8M+18.4%
CapEx$54.2M+8.2%
Free cash flow$393.6M+20.0%

Valuation & ratios

Valuation

See full
Market cap$19.34B-8.6%
Enterprise value$26.41B-6.3%
P/E24×-1.7×
P/S2.3×-0.4×

Profitability

See full
Gross margin69.9%-1.2pp
Operating margin14.2%-1.9pp
Net margin9.5%-1.0pp
FCF margin17.9%-0.9pp

Returns & leverage

See full
Return on equity6.4%-0.1pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.2×

Segments

By product

See full
Knees$828.9M+0.4%
SET$586.0M+6.4%
Hips$562.7M+5.0%
Technology And Data Bone Cement And Surgical$199.4M+21.1%

By geography

See full
Americas$1.4B+5.6%
EMEA$478.5M+4.5%
Asia Pacific$339.5M+2.2%

Competitors

Profile

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, robotic surgical systems, and digital health solutions aimed at improving patient mobility and health outcomes. Its core value proposition centers on a comprehensive portfolio that integrates traditional implants with advanced data analytics and artificial intelligence.

Competitive position

A global leader in the musculoskeletal market with a dominant position in knee and hip reconstruction and an increasing focus on robotic-assisted surgery.

GeographiesUnited States, Europe, Middle East, Africa, Asia Pacific
Customer segmentsHospitals, Ambulatory Surgery Centers, Specialist Physicians, Group Purchasing Organizations
Business modelManufacturing, Direct Sales, Consignment, Distributor-based sales
SuppliersRaw material suppliers, Specialized component manufacturers, Technology licensing partners, Third-party logistics providers
CustomersHospitals, Ambulatory surgery centers, Orthopedic surgeons, Stocking distributors, Healthcare dealers
Listed2001
Employees18.0K
CEOIvan Tornos
FilingsSEC EDGAR

FAQ

What is Zimmer Biomet Holdings's market cap?
Zimmer Biomet Holdings (ZBH) has a market capitalization of $19.3B and trades on NYSE.
What is Zimmer Biomet Holdings's revenue and profitability?
Zimmer Biomet Holdings generated $8.5B in trailing twelve-month revenue with net income of $806.6M, representing a net margin of 9.5%. Gross margin stands at 69.9%, with free cash flow of $1.5B. These figures are based on the Q2 2026 filing.
Who are Zimmer Biomet Holdings's competitors?
Zimmer Biomet Holdings's key competitors include Stryker Corporation, Johnson & Johnson MedTech, Enovis, and others. These companies compete in similar markets and product categories.
Who does Zimmer Biomet Holdings partner with?
Zimmer Biomet Holdings's notable partners include Seikagaku Corporation, Apple.
What subsidiaries does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings's subsidiaries include Biomet, Inc., LVB Acquisition, Inc..
Where is Zimmer Biomet Holdings headquartered?
Zimmer Biomet Holdings is headquartered in United States of America and employs approximately 18,000 people. It has been publicly traded since 2001.